Cited by 211Genomics and Chromatin DynamicsTGF-β signaling in diseasesUbiquitin and proteasome pathways

Transforming Growth Factor-β Stimulates p300-dependent RUNX3 Acetylation, Which Inhibits Ubiquitination-mediated Degradation

Open access
Jin, Yun-Hye, Jeon, Eun-Joo, Li, Qing-Lin, Lee, Yong Hee, Choi, Joong-Kook, Kim, Wun-Jae, Lee, Kwang-Youl, Bae, Suk-Chul·2004·Journal of Biological Chemistry

Abstract

The Runt domain transcription factors (RUNXs) play essential roles in normal development and neoplasias. Genetic analyses of animals and humans have revealed the involvement of RUNX1 in hematopoiesis and leukemia, RUNX2 in osteogenesis and cleidocranial dysplasia, and RUNX3 in the development of T-cells and dorsal root ganglion neurons and in the genesis of gastric cancer. Here we report that RUNX3 is a target of the acetyltransferase activity of p300. The p300-dependent acetylation of three lysine residues protects RUNX3 from ubiquitin ligase Smurf-mediated degradation. The extent of the acetylation is up-regulated by the transforming growth factor-beta signaling pathway and down-regulated by histone deacetylase activities. Our findings demonstrate that the level of RUNX3 protein is controlled by the competitive acetylation and deacetylation of the three lysine residues, revealing a new mechanism for the posttranslational regulation of RUNX3 expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m313120200

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HDAC3, and not HDAC4, -5, -7, or the HDAC3 Y298F mutant, is able to efficiently deacetylate two of the three Runx3 K residues (K148 and K186) previously shown to be acetylated.

    “During the screening of a library of acetylated peptides representative of the known ''acetylome,'' we have indeed observed (P.G., A.L., C.P., and C.S., unpublished data) that HDAC3, and not HDAC4, -5, -7, or the HDAC3 Y298F mutant, is able to efficiently deacetylate two of the three Runx3 K residues (K148 and K186) previously shown to be acetylated (27).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 38 · Cited by 211

Research works printed but not linked: 3

  1. Woolf, E., Xiao, C., Fainaru, O., Lotem, J., Rosen, D., Negreanu, V., Bernstein, Y., Goldenberg, D., Brenner, O., Berke, G., Levanon, D., and Groner, Y. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 7731-7736
  2. Levanon, D., Goldstein, R. E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z., and Groner, Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 11590 -11595
  3. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., and Ito, Y. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 6859 -6863

Authors
Jin, Y.-H., Jeon, E.-J., Li, Q.-L., Lee, Y. H., Choi, J.-K., Kim, W.-J., Lee, K.-Y., & Bae, S.-C.
Affiliations
Chungbuk National University (KR)
Corresponding author
  • Lee, Kwang-Youl
  • Bae, Suk-Chul
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-07
Volume
279
Issue
28
Pages
29409-29417
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1981301540
Cited by
211
References
38
Citations by year
2025: 7 · 2024: 3 · 2023: 9 · 2022: 7 · 2021: 6 · 2020: 10 · 2019: 10 · 2018: 5 · 2017: 8 · 2016: 4 · 2015: 11 · 2014: 15 · 2013: 9 · 2012: 17
FWCI
5.09
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
RUNX3, P300, histone acetylation, lysine acetylation, TGF-beta signaling, histone deacetylase, post-translational regulation, protein stability
MeSH terms
p300-CBP-Associated Factor, Acetylation, Acetyltransferases, Animals, Cell Line, DNA-Binding Proteins, Humans, Hydroxamic Acids, Lysine, Protein Processing, Post-Translational, Protein Synthesis Inhibitors, Recombinant Fusion Proteins, Transcription Factors, Signal Transduction, Transcriptional Activation, Transforming Growth Factor beta, Genes, Reporter, Cell Cycle Proteins, Ubiquitin, Ubiquitin-Protein Ligases, Core Binding Factor Alpha 3 Subunit, p300-CBP Transcription Factors, Histone Acetyltransferases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review